Products
17532 Results
Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nike Constant Leverage with ISIN code: CH1119067994 | Nike | Constant Leverage | Short | ― | 74.787 | 0.43 | 0.020 | 0.45 | 1 | -4.44% | -30.65% | -8.51% | 12 May. 2022 | |
Nike Constant Leverage with ISIN code: CH1345999507 | Nike | Constant Leverage | Short | ― | 74.787 | 0.15 | 0.020 | 0.17 | 1 | -6.25% | -44.44% | -21.05% | 18 Apr. 2024 | |
Nokia Constant Leverage with ISIN code: CH1235293177 | Nokia | Constant Leverage | Long | ― | 4.127 | 0.077 | ― | ― | 1 | 4.05% | 32.76% | 45.28% | 30 Nov. 2022 | |
Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 4.127 | 0.62 | 0.010 | 0.63 | 1 | -3.13% | 12.73% | 34.78% | 6 May. 2022 | |
Nokia Constant Leverage with ISIN code: CH1450969105 | Nokia | Constant Leverage | Long | ― | 4.127 | 21.33 | 0.170 | 21.5 | 1 | -0.14% | 30.38% | 82.62% | 21 Aug. 2025 | |
Nokia Constant Leverage with ISIN code: CH1450969097 | Nokia | Constant Leverage | Short | ― | 4.127 | 3.67 | 0.020 | 3.69 | 1 | -2.39% | -22.41% | -50.14% | 21 Aug. 2025 | |
Nokia Constant Leverage with ISIN code: CH1235293169 | Nokia | Constant Leverage | Short | ― | 4.127 | 1.11 | 0.010 | 1.12 | 1 | -2.63% | -15.27% | -35.47% | 30 Nov. 2022 | |
Novartis Constant Leverage with ISIN code: CH1423416671 | Novartis | Constant Leverage | Long | ― | 105.19 | 21.48 | 0.140 | 21.62 | 1 | 12.40% | 105.35% | -1.96% | 12 May. 2025 | |
Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 105.19 | 11.6 | 0.030 | 11.63 | 1 | 4.13% | 29.75% | 5.26% | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 105.19 | 1.22 | 0.010 | 1.23 | 1 | 9.91% | 79.41% | 1.67% | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 105.19 | 7.87 | 0.030 | 7.9 | 1 | 6.21% | 46.55% | 5.64% | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 105.19 | 3.79 | 0.020 | 3.81 | 1 | 8.29% | 64.07% | 4.70% | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 105.19 | 0.48 | 0.010 | 0.49 | 1 | -11.11% | -38.46% | -22.58% | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 105.19 | 1.71 | 0.010 | 1.72 | 1 | -6.04% | -26.61% | -13.64% | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 105.19 | 0.53 | 0.010 | 0.54 | 1 | -17.19% | -64.90% | -47.52% | 12 May. 2025 | |
Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 105.19 | 0.1 | 0.010 | 0.11 | 1 | -28.57% | -54.55% | -41.18% | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 105.19 | 0.99 | 0.010 | 1 | 1 | -13.91% | -57.14% | -38.89% | 12 May. 2025 | |
Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 373.086 | 12.71 | 0.100 | 12.81 | 1 | -1.32% | 38.15% | -21.64% | 21 Aug. 2025 | |
Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 373.086 | 0.024 | ― | ― | 1 | 0.00% | 118.18% | 71.43% | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 373.086 | 14.29 | 0.080 | 14.37 | 1 | -0.69% | 28.85% | -9.21% | 21 Aug. 2025 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.